Ambrx Biopharma Inc. Debt to Equity Ratio 2023-2023 | AMAM
Current and historical debt to equity ratio values for Ambrx Biopharma Inc. (AMAM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Ambrx Biopharma Inc. debt/equity for the three months ending June 30, 2023 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2023-06-30 |
$0.03B |
$0.25B |
0.12 |
2023-03-31 |
$0.03B |
$0.18B |
0.15 |
2022-12-31 |
$0.03B |
$0.12B |
0.25 |
2022-06-30 |
$0.04B |
$0.14B |
0.28 |
2022-03-31 |
$0.00B |
|
0.00 |